Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?
Annotations already indicate read-only, idempotent, non-destructive behavior. Description adds valuable context by specifying the exact data fields (indications, dosage, warnings, interactions, contraindications) and the OpenFDA source, enhancing transparency beyond annotations.
Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.